Purple Biotech (PPBT)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $2.65M
Last updated: Nov 17, 2026 at 4:15 PM ET
Purple Biotech (PPBT) Statistics
Purple Biotech (PPBT) has a market cap of $2.65M. Its share count is up 296.93% from a year earlier. It holds $5.10M more cash than debt, 192.40% of its market cap.
Total Valuation
| Market Cap | $2.65M |
|---|---|
| Latest price (Nov 17, 2026) | $1.71 |
Key Dates
| Last Earnings Date | Aug 7, 2026 |
|---|---|
| Fiscal Year End | December |
Valuation Ratios
| P/B Ratio | 1.5x |
|---|---|
| P/TBV Ratio | 3.8x |
Price Statistics
The stock is down 76.19% over 52 weeks and trades 23.02% above its 50-day average.
| Beta (1Y) | 0.08 |
|---|---|
| 52-Week Change | -76.19% |
| 1-Month Change | +58.33% |
| 3-Month Change | +7.55% |
| 6-Month Change | -51.28% |
| 5-Year Change | -99.86% |
| 10-Year Change | -99.98% |
| Total Return (1Y) | -76.19% |
| Total Return (3Y CAGR) | -79.54% |
| Total Return (5Y CAGR) | -71.00% |
| Return vs SPY (1Y) | -90.21% |
| Max Drawdown (1Y) | -89.43% |
| Max Drawdown (3Y) | -99.58% |
| Sharpe Ratio (1Y) | -1.57 |
| Correlation with SPY (1Y) | 0.01 |
| 50-Day Average | $1.39 |
| 200-Day Average | $2.72 |
| 52-Week Range | $0.91 to $8.90 |
| RSI (14 Days) | 72.8 |
| Average Volume (20 Days) | 30.95K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 3.70x current liabilities, and total debt is 0.01x shareholder equity.
| Current Ratio | 3.70x |
|---|---|
| Quick Ratio | 3.70x |
| Debt / Equity | 0.01x |
| Interest Coverage | -360.69x |
Returns and Efficiency
Return on invested capital is -156.20% over the last 12 months, against a 5-year average of -71.63%.
| Return on Equity (ROE) | -199.60% |
|---|---|
| Return on Assets (ROA) | -172.90% |
| Return on Invested Capital (ROIC) | -156.20% |
| Return on Capital Employed (ROCE) | -198.07% |
| ROE (5Y Average) | -85.27% |
| ROA (5Y Average) | -56.09% |
| ROIC (5Y Average) | -71.63% |
Scores
PPBT has a Piotroski F-Score of 1 of 9, in the weak band of 0 to 2.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 1 of 9 |
|---|---|
| Piotroski Strength | Weak |
Income Statement
Revenue was $0 over the last 12 months.
| Revenue | $0 |
|---|---|
| Operating Income | -$28.36M |
| Pretax Income | -$24.59M |
| Net Income | -$24.49M |
| EBITDA | -$24.28M |
| EBIT | -$24.53M |
| Reported EPS (TTM) | -$4.52 |
Trailing 12 months through Jun 30, 2026.
Balance Sheet
Shareholder equity funds 86.59% of the $14.17M in total assets.
| Cash and Equivalents | $5.24M |
|---|---|
| Total Debt | $134.00K |
| Net Cash | $5.10M |
| Working Capital | $4.81M |
| Shareholder Equity | $12.27M |
| Tangible Book Value | $4.91M |
| Total Assets | $14.17M |
| Total Liabilities | $1.95M |
Balance sheet as of Jun 30, 2026.
Cash Flow
After $2.05M of capital spending, operating cash flow left -$9.81M of free cash flow.
| Operating Cash Flow | -$7.76M |
|---|---|
| Capital Expenditures | $2.05M |
| Free Cash Flow | -$9.81M |
| FCF Per Share | -$6.03 |
| Depreciation and Amortization | $246.00K |
Trailing 12 months through Jun 30, 2026.
Stock Splits
The last split was a 1-for-10 reverse split on Mar 2, 2026.
| Last Split Date | Mar 2, 2026 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:10 |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About PPBT
What is PPBT's market cap?
Purple Biotech has a market cap of $2.65M.
How many shares of PPBT are outstanding?
Purple Biotech has 10.86M shares outstanding. The count is up 296.93% from a year earlier.
Does PPBT pay a dividend?
No. Purple Biotech does not pay a dividend.
How much debt does PPBT have?
Purple Biotech has $134.00K of total debt and $5.24M of cash and equivalents, a net cash position of $5.10M.
PPBT pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors